[Prescription, monitoring of antithrombotic treatment: 1--antiplatelet agents].
Drouet
Ludovic
L
PU-PH, département d'angio-hématologie et clinique des anticoagulants Ile-de-France, hôpital Lariboisière, Paris Cedex. ludovic.drouet@lrb.aphp.fr
D000284:Administration, Oral; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D000075202:Contraindications; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D004338:Drug Combinations; D016903:Drug Monitoring; D011307:Drug Prescriptions; D004351:Drug Resistance; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D011725:Pyridines / Q000627:therapeutic use; D013514:Surgical Procedures, Operative; D015912:Thrombolytic Therapy; D020246:Venous Thrombosis / Q000517:prevention & control
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D016861:Cyclooxygenase Inhibitors; D004338:Drug Combinations; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D011725:Pyridines; C446540:thienopyridine; D001241:Aspirin